Dr Emna Harigua, a researcher at the Pasteur Institute in Tunis, has been awarded the Pasteur Network Talent Award 2026 – AI Edition. The award was presented on November 4, 2026, during the annual meeting of the Pasteur Network, held in Laval, Canada. This recognition highlights Dr Harigua's outstanding contributions to the intersection of artificial intelligence, structural bioinformatics, and molecular modeling applied to drug discovery.
The Pasteur Network Talent Awards aim to acknowledge and support scientific talent within the network, promoting innovative research, scientific excellence, and leadership. The selection process is highly competitive, with candidates evaluated based on the quality of their research, originality, and potential impact of their proposed project, as well as their ability to communicate their scientific vision. Dr Harigua's award-winning project, "AI-Driven Medicinal Chemistry for Next-Generation Anti-Leishmania Drug Design," focuses on developing computational approaches that integrate artificial intelligence to accelerate the identification of new therapeutic candidates.
The 2026 edition of the Pasteur Network Talent Award is particularly significant, as it is the first to be dedicated specifically to artificial intelligence. This reflects the growing role of AI in transforming biomedical research and addressing major global health challenges. Dr Harigua's work at the interface of AI, bioinformatics, and molecular modeling has been recognized for its potential to drive innovation in medicinal chemistry and tackle infectious diseases.
As the head of a research team at the Pasteur Institute in Tunis, Dr Harigua is committed to developing innovative computational approaches that leverage AI to accelerate the discovery of new therapeutic candidates. Her research focuses on infectious diseases, with a particular emphasis on Leishmaniasis. The Pasteur Network Talent Award 2026 will support Dr Harigua's ongoing research and provide her with a platform to further develop her scientific leadership.
The Pasteur Network, a global network of research institutions, aims to promote scientific collaboration and excellence in biomedical research. The annual meeting, where Dr Harigua received her award, brings together researchers from around the world to share their work, discuss emerging trends, and foster collaborations. Dr Harigua's achievement is a testament to the quality of research conducted at the Pasteur Institute in Tunis and the growing recognition of Tunisian scientists on the international stage.
Dr Harigua's award-winning project has the potential to make a significant impact on the development of new treatments for Leishmaniasis, a disease that affects millions of people worldwide. By harnessing the power of AI and machine learning, Dr Harigua's research aims to accelerate the discovery of new therapeutic candidates and improve our understanding of the disease. The recognition she has received will help raise awareness about the importance of her research and the need for continued investment in scientific innovation.
The Pasteur Network Talent Award 2026 is a prestigious recognition that highlights Dr Harigua's exceptional scientific talent and her contributions to the field of AI-driven medicinal chemistry. This award will not only support her ongoing research but also inspire other young scientists to pursue innovative and impactful research in the field. Dr Harigua's achievement serves as a role model for aspiring researchers, demonstrating the potential for scientific excellence and leadership in Tunisia and beyond.
Key points
- Dr Emna Harigua receives Pasteur Network Talent Award 2026 for her AI-driven medicinal chemistry research.
